FDA Inspection
Fayz A. Hudefi, M.D.FDA Inspection 1131413 - Fayz A. Hudefi, M.D. - September 16, 2020
Record Details
This FDA Inspection record concerns Fayz A. Hudefi, M.D., with an inspection on September 16, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Fayz A. Hudefi, M.D.
- Inspection Date
- September 16, 2020
- Product Type
- Drugs
View Company Profile
ID · eabc84af-cc3f-444b-b514-c14053727c8d
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1131413
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Fayz A. Hudefi, M.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 20, 2024 | VAI | Dallas District Office | Bioresearch Monitoring: Human Drugs |
| April 21, 2023 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Fayz A. Hudefi, M.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.